| | 
Part, Chapter, Paragraph
501 II, 9. 1. 2 | 9.1.2.6. Future developments~ ~The
502 II, 9. 1. 2 | Community Genetics 2007; 10:93-6.~De Wals P et al, (2007):
503 II, 9. 1. 2 | and Gynecology, Vol 25, pp 6-11.~Garne E, Loane M, de
504 II, 9. 2. 2 | indicators are published as Table 6 of the report as far as
505 II, 9. 2. 3 | 15.3% for England, and 14.6% in Ireland, which rank
506 II, 9. 2. 6 | 9.2.6. Future developments~ ~EU
507 II, 9. 3. 1 | EU varies between 3 and 6 per 1 000 inhabitants. In
508 II, 9. 3. 1 | 20–64 (prevalence about 6 per 1000) and 0.6 million
509 II, 9. 3. 1 | about 6 per 1000) and 0.6 million aged 65 or older (
510 II, 9. 3. 1 | increasing from 2.1 to 4.6 to 16.0 per 100 000 population
511 II, 9. 3. 1 | distribution” (WHO, 2000, p.6), and with the recognition
512 II, 9. 3. 1 | 9.3.1.6. Future developments~ ~Key
513 II, 9. 3. 1 | of Impotence Research. 12(6): p. 305-311.~ ~British
514 II, 9. 3. 1 | veille sanitaire, No. 72. p 6~ ~European Agency for Health
515 II, 9. 3. 1 | of clinical practice, 62(6):973-6~ ~Lee H, McGovern
516 II, 9. 3. 1 | clinical practice, 62(6):973-6~ ~Lee H, McGovern K, Finkelstein
517 II, 9. 3. 1 | Medscape General Medicine; 6: 3: 49.~ ~Men and Gender
518 II, 9. 3. 1 | Review Journal, 11(4), 3-6.~ ~White AK , Cash K (2003):
519 II, 9. 3. 2 | 9.3.2.6. Future developments~ ~There
520 II, 9. 3. 2 | outcomes. Nicotine Tob Res 2004;6 Suppl 2:S125-40.~ ~De Galan-Roosen
521 II, 9. 3. 2 | Epidemiol 2001;15(3):315-6.~ ~Glinianaia SV, Pharoah
522 II, 9. 3. 2 | Reprod Med 2004;49(10):812-6.~ ~Maher J, Macfarlane A (
523 II, 9. 3. 2 | Gynaecol 1994;101(4):301-6.~ ~Reddy UM, Ko CW, Willinger
524 II, 9. 3. 2 | Group. N Engl J Med 2000;343(6):378-84.~ ~Zeitlin J, Blondel
525 II, 9. 3. 3 | while a quarter of men and 6% of women have had 10 or
526 II, 9. 3. 3 | same-sex activity in men is 6% in the UK (Johnson A, 2001)
527 II, 9. 3. 3 | Czech Republic, 5% of men and 6% of women reported occasional
528 II, 9. 3. 3 | 1/3 in East Germany to 1/6 in the UK (Bochow et al,
529 II, 9. 3. 3 | 9.3.3.6. References~ ~Amaro F, Frazão
530 II, 9. 3. 3 | European countries. AIDS Care 6(5) :533-49.~Bozon M, Kontula
531 II, 9. 4. 3 | for women, including 5 to 6 years with severe limitations).
532 II, 9. 4. 3 | chronic illnesses and 2-6 times more likely to have
533 II, 9. 4. 6 | 9.4.6. Future developments~ ~The
534 II, 9. 4. 7 | Ageing; Volume 33, Number 6, November 2004 , pp. 618-
535 II, 9. 4. 7 | Transmitted Infections;75(6):449.~ ~Jassem J, Senkus-Konefka
536 II, 9. 4. 7 | Breast Cancer Res. 2004, 6:148-152. Available at: htt 48
537 II, 9. 5. 3 | sexual assault as adults~· 6.4% reported rape as adults~
538 II, 9. 5. 3 | One in 4 women and 1 in 6 men will experience domestic
539 II, 9. 5. 3 | Greece the rate was 11% and 6% respectively (Jernigan,
540 II, 9. 5. 3 | Jernigan, 2001).~ ~Table 9.5.6 below illustrates drinking
541 II, 9. 5. 3 | and Ireland.~ ~Table 9.5.6. Drinking patterns among
542 II, 9. 5. 3 | 1.7 kg) and Ireland (1.6 kg) (Eurobarometer, 2006).
543 II, 9. 5. 3 | between 25 and 54 was 23.6% in 2006 in the EU27, compared
544 II, 9. 5. 5 | Council Conclusions of 2.6.2006 on gender equality
545 II, 9. 5. 6 | 9.5.6. References~ ~Age Concern (
546 II, 9. 5. 6 | Medicine Volume 346:393-403, No 6 February 7 2002~ ~Doyal
547 II, 9. 5. 6 | News Release, 29/2006 - 6 March 2006~ ~Eurostat (2007):
548 II, 9. 5. 6 | News Release. 169/2007 - 6 December 2007. Available
549 II, 9. 5. 6 | Pride. Body and Society, 6(1), pp. 13-28.~ ~Risberg
550 III, 10. 1. 3 | disorders. Am J Psychiatry 147(6):685-695.~Lindenberg CS,
551 III, 10. 1. 3 | Arch Dermatol 136(12):1544-6.~Szklo M, Nieto J (2005):
552 III, 10. 1. 3 | relationship? Sports Med 6(3):135-145.~Veenstra MY,
553 III, 10. 1. 3 | Germany. J Public Health 13(6):291-295.~Wiers RW, Sergeant
554 III, 10. 2. 1 | from 15.9% in Sweden to 37.6% in Greece. Despite wide
555 III, 10. 2. 1 | decades later (Figure 10.2.1.1.6).~ ~Figure 10.2.1.1.6. Features
556 III, 10. 2. 1 | 1.6).~ ~Figure 10.2.1.1.6. Features of the tobacco
557 III, 10. 2. 1 | was 17.9% at home and 20.6% at work. At the follow
558 III, 10. 2. 1 | countries, representing 6% of the global population,
559 III, 10. 2. 1 | 10.2.1.1.6. Future developments~ ~Despite
560 III, 10. 2. 1 | wanting to quit smoking (6) complete the six effective
561 III, 10. 2. 1 | Health Perspect, 2006; 114(6): 853-858. Available at: htt ~ ~
562 III, 10. 2. 1 | their life, and over 1 in 6 (18%) have binged (5+ drinks
563 III, 10. 2. 1 | risk increased to at least 6 times with a BAC between
564 III, 10. 2. 1 | 10,000 suicides (1 in 6 of all suicides)~- 16% of
565 III, 10. 2. 1 | consumption (Figure 10.2.1.2.6). The best predictors of
566 III, 10. 2. 1 | taxes.~ ~Figure 10.2.1.2.6. Alcohol consumption and
567 III, 10. 2. 1 | re-instituted, there was a 3.6% increase in alcohol sales (
568 III, 10. 2. 1 | of school children with 6 EU countries reaching the
569 III, 10. 2. 1 | use ranges from 0.3% to 7.6%.~ ~Figure 10.2.1.3.2. Overview
570 III, 10. 2. 1 | users in the range of 3 to 6 per 1 000 inhabitants aged
571 III, 10. 2. 1 | ranging between 0.5 and 6 cases per year for a population
572 III, 10. 2. 1 | prevalent. See Figure 10.2.1.3.6 for national and subnational
573 III, 10. 2. 1 | lives.~ ~Figure 10.2.1.3.6. Estimated HCV antibody
574 III, 10. 2. 1 | mortality among drug users is 6-20 times higher for males
575 III, 10. 2. 1 | Between 1990 and 2004, from 6 500 to over 9 000 deaths
576 III, 10. 2. 1 | 10.2.1.3.6. References~ ~Bargagli et
577 III, 10. 2. 1 | 40-50% for adults. Only 5-6% of gum sites showed inflammation.
578 III, 10. 2. 1 | fluoride (250-750 ppm for 3-6 year old children) is an
579 III, 10. 2. 1 | 10.2.1.5.6. References~ ~Arnadottir
580 III, 10. 2. 1 | Changing oral health status of 6- and 12-year-old schoolchildren
581 III, 10. 2. 1 | Dent Health. 2003; 20:211-6.~ ~Euromonitor International (
582 III, 10. 2. 1 | J Dent Res 2003; 82:~361-6.~ ~Marinho VC, Higgins JP,
583 III, 10. 2. 1 | 10.2.1.6. Inadequate physical activity~ ~
584 III, 10. 2. 1 | 10.2.1.6.1. Introduction~ ~Physical activity
585 III, 10. 2. 1 | 10.2.1.6.2. Data sources~ ~Surveillance
586 III, 10. 2. 1 | 10.2.1.6.3. Data description and
587 III, 10. 2. 1 | physical activity (Figure 10.2.6.1). On average, only 31%
588 III, 10. 2. 1 | with age.~ ~Figure 10.2.1.6.1. Proportion of adults (
589 III, 10. 2. 1 | Portugal.~ ~Figure 10.2.1.6.2. Prevalence of sufficient
590 III, 10. 2. 1 | both sexes.~ ~Figure 10.2.1.6.3. Average proportion of
591 III, 10. 2. 1 | 600 000 deaths per year (6% of total deaths) and 5.
592 III, 10. 2. 1 | Europe are shorter than 6 km, a distance that could
593 III, 10. 2. 1 | 10.2.1.6.4. Control tools and policies~ ~
594 III, 10. 2. 1 | 10.2.1.6.5. Future developments~ ~
595 III, 10. 2. 1 | 10.2.1.6.6. References~ ~Bauman A
596 III, 10. 2. 1 | 10.2.1.6.6. References~ ~Bauman A and
597 III, 10. 2. 1 | on-line publication, accessed 6 June 2007).~ ~Estabrooks
598 III, 10. 2. 1 | Journal of Healthy Promotion, 6:338-344.~ ~Paffenbarger
599 III, 10. 2. 1 | November 2004 (htt f, accessed 6 June 2007).~ ~TNS Opinion
600 III, 10. 2. 1 | 2004) preschool children (2-6 years of age) were overweight.
601 III, 10. 2. 1 | overweight was found in Spain (6–9 years old, 35.2%) (Aranceta-Bartrina
602 III, 10. 2. 1 | the Netherlands (boys: 11.6%; girls: 8.6%) and Denmark (
603 III, 10. 2. 1 | Netherlands (boys: 11.6%; girls: 8.6%) and Denmark (boys: 12.
604 III, 10. 2. 1 | the lowest in Italy (33.6%) (Gallus et al, 2006),
605 III, 10. 2. 1 | obesity ranged from 7.4% to 26.6% among men and between 8.
606 III, 10. 2. 1 | Health, 2001) and Hungary (0.6 percentage points for both
607 III, 10. 2. 1 | overweight at the ages of 6, 9 and 15 years (Johannsson
608 III, 10. 2. 1 | nutrition accounted for 4.6% of all DALYs lost, obesity
609 III, 10. 2. 1 | reported in Figure 10.2.1.7.6.~ ~Figure 10.2.1.7.5. Gross
610 III, 10. 2. 1 | 1995=100)~ ~Figure 10.2.1.7.6. Average annual growth rate
611 III, 10. 2. 1 | products.~ ~Table 10.2.1.7.6. Comparisons between European
612 III, 10. 2. 1 | 10.2.1.7.6. Risk reduction strategies~ ~
613 III, 10. 2. 1 | obesity in children aged 6.0-9.9 years in order to
614 III, 10. 2. 1 | report online, accessed on 6 February 2008).~ ~WHO Regional
615 III, 10. 2. 1 | report online, accessed on 6 February 2008).~ ~WHO Regional
616 III, 10. 2. 4 | 10.2.4.6. References~ ~Brand A (2002):
617 III, 10. 2. 5 | 10.2.5.6. References~Allen JP, Porter
618 III, 10. 2. 5 | Mental Health Journal 2002;23(6):606-24. Available at http ~ ~
619 III, 10. 3. 1 | 10.3.1.6. References~ ~Babisch W (
620 III, 10. 3. 2 | Management (ICCM) in Dubai on 6 February 2006. SAICM was
621 III, 10. 3. 2 | 10.3.2.6. References~ ~Asia-Europe
622 III, 10. 3. 2 | Second Edition Chapter 6.11 Platinum. WHO Europe.
623 III, 10. 3. 3 | Data sources~ ~See Chapter 6.~ ~
624 III, 10. 3. 3 | and policies~ ~See Chapter 6.~ ~ ~
625 III, 10. 3. 3 | developments~ ~See Chapter 6.~ ~ ~
626 III, 10. 3. 3 | 10.3.3.6. References~ ~See Chapter
627 III, 10. 3. 3 | References~ ~See Chapter 6.~ ~
628 III, 10. 3. 4 | emissions will only be 0.6% below base-year levels
629 III, 10. 3. 4 | water scarcity. It affected 6 million people in the European
630 III, 10. 3. 4 | 10.3.4.6. References~ ~Solomon, 2007~
631 III, 10. 4. 1 | studies in the USA and Canada (6-city study, 12-city and
632 III, 10. 4. 1 | 10.4.1.6. References~ ~AirBase –
633 III, 10. 4. 1 | Organization, 2006 (htt , accessed 6 March 2007).~ ~WHO (2005):
634 III, 10. 4. 2 | contaminants in the food chain; (6) additives and products
635 III, 10. 4. 2(32)| OJ 186, 30.6.1989, p.23~
636 III, 10. 4. 2 | is laid down in Article 6 of the TSE Regulation and
637 III, 10. 4. 2 | accordance with Article 6.4 specified in Chapter B.
638 III, 10. 4. 2 | Campylobacteriosis~51.6 per 100 000~Increasing (
639 III, 10. 4. 2 | an incidence rate of 51.6 cases per 100,000 people
640 III, 10. 4. 2 | below the standard~(WHO: 1.6 ug/kg body~weight per day)~ ~ ~
641 III, 10. 4. 2 | of the PPR Panel (Art 22.6 of EFSA Regulation 178/2000):~·
642 III, 10. 4. 2 | approaches and methodologies: 6 GDs are currently under
643 III, 10. 4. 2 | modified food and feed (6). Where a food product contains
644 III, 10. 4. 2 | into the EU.~ ~Table 10.4.2.6. FVO Inspection Objectives
645 III, 10. 4. 2 | 10.4.2.6. References~ ~European Commission (
646 III, 10. 4. 2 | European Communities No. L 109, 6 May 2000. Available at:~htt ~ ~
647 III, 10. 4. 3 | 70.0 (per 100 000) to 21.6 in the Commonwealth of Independent
648 III, 10. 4. 3 | CIS), and from 176.3 to 44.6 in the CARK (5 Central Asian
649 III, 10. 4. 3 | 20 outbreaks (27%) and 60.6% of cases of illness. Four
650 III, 10. 4. 3 | 10.4.3.6. References~ ~European Commission (
651 III, 10. 4. 5 | land-filling, 42% is recycled, 6% is incinerated with energy
652 III, 10. 4. 5 | pan-European region is more than 6 billion tonnes. The amount
653 III, 10. 4. 5 | EU-15+EFTA, it declined by 6 % in the same period in
654 III, 10. 4. 5 | landfilled, 42 % is recycled, 6 % is incinerated with energy
655 III, 10. 4. 5 | country~ ~Figure 10.4.5.2.6. Detailed analysis of industrial
656 III, 10. 4. 5 | inventories ((Figure 10.4.5.2.6).~ ~The range of contaminants
657 III, 10. 5. 1 | Pneumophila (see chapter 6).~ ~Construction materials
658 III, 10. 5. 1 | Lebensmittelsicherheit, 2008) (see chapter 6 for fatal and non-fatal
659 III, 10. 5. 1 | 10.5.1.6. Transport~ ~The need for
660 III, 10. 5. 1 | 10.5.1.6. Other issues~ ~Household
661 III, 10. 5. 1 | Abnormal Child Psychology 35(6):1021-33.~Brenner BL et
662 III, 10. 5. 1 | Health Perspectives, 115(6): 965-970.~Available at: htt df~
663 III, 10. 5. 1 | Public Health, Vol. 16, No. 6, 583–591;~ ~Wargocki P,
664 III, 10. 5. 2 | rural settlements, males~ ~Figure 10.5.2.6. Correlation between age-adjusted
665 III, 10. 5. 2 | 10.5.2.6. References~ ~British Medical
666 III, 10. 5. 2 | BMC Public Health 2006, 6:312~[http://www.biomedcentral.
667 III, 10. 5. 2 | biomedcentral.com/1471-2458/6/312] (accessed on 19 September
668 III, 10. 5. 2 | BMC Family Practice 2005, 6:16.~[http://www.biomedcentral.
669 III, 10. 5. 2 | biomedcentral.com/1471-2296/6/16] (accessed on 19 September
670 III, 10. 5. 2 | BMC Public Health 2006, 6:146~[http://www.biomedcentral.
671 III, 10. 5. 2 | biomedcentral.com/1471-2458/6/146] (accessed on 19 September
672 III, 10. 5. 3 | Euro for Austria and 12.6 for Belgium. In many countries,
673 III, 10. 5. 3 | year 2000.~ ~Table 10.5.3.6 gives time trends with respect
674 III, 10. 5. 3 | increased.~ ~Table 10.5.3.6. Change in the number of
675 III, 10. 5. 3 | to be between 1:2 and 1:6 (Kreis and Boedeker, 2004b).~
676 III, 10. 5. 3 | 10.5.3.6. References~ ~Aldana StG,
677 III, 10. 6 | 10.6. Social determinants~ ~ ~
678 III, 10. 6. 1 | 10.6.1. Social networks and social
679 III, 10. 6. 1 | 10.6.1.1. Introduction~ ~Social
680 III, 10. 6. 1 | 10.6.1.2. Data sources~ ~
681 III, 10. 6. 1 | 10.6.1.2.1 The Mental health
682 III, 10. 6. 1 | 10.6.1.2.2 The Eurobarometer
683 III, 10. 6. 1 | 10.6.1.2.3. The SHARE survey~
684 III, 10. 6. 1 | 10.6.2.4 The HBSC study~The Health
685 III, 10. 6. 1 | 10.6.2.5 The World Values Survey~
686 III, 10. 6. 1 | 10.6.1.3. Data description and
687 III, 10. 6. 1 | support categories.~ ~Table 10.6.1. Social support by country
688 III, 10. 6. 1 | in Belgium.~ ~Figure 10.6.1. Frequency of contact
689 III, 10. 6. 1 | al., 2008).~ ~Figure 10.6.2. 15-year old girls in
690 III, 10. 6. 1 | same gender~ ~Figure 10.6.3. 15-year old boys in the
691 III, 10. 6. 1 | al., 2008).~ ~Figure 10.6.4. Use of electronic media
692 III, 10. 6. 1 | et al, 2005).~ ~Figure 10.6.5. Exposures to assaults
693 III, 10. 6. 1 | 10.6.1.4. Control tools and policies~ ~
694 III, 10. 6. 1 | 10.6.1.5. Future developments~ ~
695 III, 10. 6. 1 | 10.6.1.6. References~ ~Austin
696 III, 10. 6. 1 | 10.6.1.6. References~ ~Austin DM,
697 III, 10. 6. 1 | 10.6.1.7. Acronyms~ ~HBSC~Health
698 III, 10. 6. 2 | 10.6.2. Socio-economic determinants~ ~ ~
699 III, 10. 6. 2 | 10.6.2.1. Introduction~ ~In line
700 III, 10. 6. 2 | 10.6.2.2. Data sources~ ~ ~The
701 III, 10. 6. 2 | 10.6.2.3. Data description and
702 III, 10. 6. 2 | than in women (Figure 10.6.2.1). Inequalities in mortality
703 III, 10. 6. 2 | to education (Figure 10.6.2.2). These inequalities
704 III, 10. 6. 2 | expectancy at birth (4 to 6 years among men, 2 to 4
705 III, 10. 6. 2 | mortality decline.~ ~Figure 10.6.2.1. Educational inequalities
706 III, 10. 6. 2 | Countries per cause~ ~Figure 10.6.2.2. Inequalities in mortality
707 III, 10. 6. 2 | educational groups (Table 10.6.2.1).~ ~Table 10.6.2.1.
708 III, 10. 6. 2 | Table 10.6.2.1).~ ~Table 10.6.2.1. Odds Ratio Chronic
709 III, 10. 6. 2 | 10.6.2.4. Control tools, actions
710 III, 10. 6. 2 | environments and products~6. Health and medical care
711 III, 10. 6. 2 | 10.6.2.5. Future developments~ ~
712 III, 10. 6. 2 | 10.6.2.6. References~ ~Berkman,
713 III, 10. 6. 2 | 10.6.2.6. References~ ~Berkman, L. &
714 III, 10. 6. 2 | 10.6.2.7. Acronyms~ ~CSDH Commission
715 III, 10. 6. 3 | 10.6.3. Violence and other behaviours
716 III, 10. 6. 3 | 10.6.3.1. Introduction~ ~Assaults
717 III, 10. 6. 3 | 10.6.3.2. Data sources~ ~The
718 III, 10. 6. 3 | 10.6.3.3. Data description and
719 III, 10. 6. 3 | other offences. Figure 10.6.3.1. shows the results.
720 III, 10. 6. 3 | Spain (below 2%). Figure 10.6.3.1. shows national rates.~ ~
721 III, 10. 6. 3 | national rates.~ ~Figure 10.6.3.1. Prevalence rates for
722 III, 10. 6. 3 | see Tables 9.5.5 and 9.5.6). Not all assaults result
723 III, 10. 6. 3 | 10.6.3.4. Control tools and policies~ ~
724 III, 10. 6. 3 | 10.6.3.5. References~ ~EUICS (
725 IV, 11. 1. 4 | Thomson 2003) (see Section 11.6 on Financing health care).
726 IV, 11. 1. 5 | Austria and Switzerland (6.5 and over), the lowest
727 IV, 11. 1. 6 | regulation (see Section 11.6 Financing Health Care).
728 IV, 11. 2. 2 | countries, e.g. Austria (from 1.6% total health spending in
729 IV, 11. 3. 1 | financial reasons.~ ~Table 11.6. Numbers of practising physicians,
730 IV, 11. 3. 1 | medical school in Europe is 5-6 years, with residency of
731 IV, 11. 3. 1 | years, with residency of 2-6 years and a life-long continuing
732 IV, 11. 3. 2 | in Belgium, 4 in Sweden, 6.9 in Finland and 9% in the
733 IV, 11. 3. 2 | years 2008-2010~ ~Figure 11.6. Therapeutic focus of products
734 IV, 11. 3. 2 | overall product-mix (figure 11.6.).~ ~
735 IV, 11. 5. 4 | fluctuate in Europe from 6% to 42%. Again, these differences
736 IV, 11. 5. 6 | 11.5.6. Policy tools~ ~European
737 IV, 11. 6 | 11.6. Financing healthcare~ ~
738 IV, 11. 6. 1 | 11.6.1. Health expenditure patterns
739 IV, 11. 6. 2 | 11.6.2. Description and assessment
740 IV, 11. 6. 3 | 11.6.3. Progressiveness of funding~ ~
741 IV, 11. 6. 4 | 11.6.4. Description of arrangements
742 IV, 11. 6. 5 | Resources for Health 1: 6.~ ~Carter AO, Battista RN
743 IV, 11. 6. 5 | Journal Quality Health Care 13(6): 439-46.~ ~Evans RG, Barer
744 IV, 11. 6. 5 | European Union. Euro Observer. 6: 1-4.~ ~Jones A, Duncan
745 IV, 11. 6. 5 | Research and Policy 4(2): 122-6.~ ~Kelley E, Hurst J (2006):
746 IV, 11. 6. 5 | Nationalökonomie und Statistik 217(6): 718-40.~ ~Macinko J, Starfield
747 IV, 11. 6. 5 | Journal of Health Economics 6(S1): 2-10.~ ~Scitovsky AA (
748 IV, 11. 6. 5 | Services Research and Policy 6: 145-50.~ ~Starfield B,
749 IV, 12. 1 | services)~ ~Art. 95 (3), (6) and (8) concerning health
750 IV, 12. 1 | internal market~ ~Art. 133(6) concerning common commercial
751 IV, 12. 1 | research~Frame work~Program me 6~Providing EU co-funding
752 IV, 12. 2 | countries, representing 6% of the global population,
753 IV, 12. 2 | re-instituted, there was a 3.6% increase in alcohol sales.~ ~
754 IV, 12. 4 | than D.G. SANCO (Table 12.6).~ ~Table 12.6. Health across
755 IV, 12. 4 | Table 12.6).~ ~Table 12.6. Health across the European
756 IV, 12. 4 | activities, with a budget of € 6 billion under the 7th Framework
757 IV, 12. 6 | 12.6. The Public Health Forum~ ~
758 IV, 12. 7 | during the PT Presidency on 5-6 November 2007 launched the
759 IV, 12. 10 | use~ high~Act No. 512 of 6 June 2007~Smoke-free Environments
760 IV, 12. 10 | with children between 1-6 years of age to adopt a
761 IV, 12. 10 | physical activity is included.~ ~B. "6 a day" consists of an information
762 IV, 12. 10 | this phase.~o The last 5-6 years citizens are encouraged
763 IV, 12. 10 | inclusive work practices~6. supporting the adaptability
764 IV, 12. 10 | public health~ ~ Law 2004-800 6 August 2004 concerning the
765 IV, 12. 10 | linked to objective domains 6-11 as well as economic security,
766 IV, 12. 10 | environments and products~6. A more health-promoting
767 IV, 13.Acr | spending in Denmark and 0.6% in Italy, to 4.9% in the
768 IV, 13. 2. 2 | i.e: estimated to be 2-6% of the total burden of
769 IV, 13. 2. 2 | disorder accounting for 6.2% YLDs).~· Among children
770 IV, 13. 2. 2 | region (51 countries), 2-6% of deaths from all causes
771 IV, 13. 2. 2 | nutrition accounted for 4.6% of all DALYs lost, obesity
772 IV, 13. 2. 3 | developed world range from 2-6%.~ ~Table 13.4. Burden of
773 IV, 13. 2. 3 | determinants in Table 13.6 are typically associated
774 IV, 13. 2. 3 | region (51 countries), 2-6 % of deaths from all causes
775 IV, 13. 2. 4 | Table 13.8).~ ~ ~Table 13.6. WHO estimates for preventable
776 IV, 13. 2. 4 | European Union (Table 13.6) are smoking, having a high
777 IV, 13. 2. 4 | data reported in Table 13.6 that these risk factors
778 IV, 13. 4 | An amount close to € 2.6 bn, (3.6%) will be allocated
779 IV, 13. 4 | amount close to € 2.6 bn, (3.6%) will be allocated in the
780 IV, 13. 5 | European Parliament and 6 European NGOs representing
781 IV, 13. 6 | 13.6. Prioritising children’s
782 IV, 13. 6. 1 | 13.6.1 Measurement of burden
783 IV, 13. 6. 2 | 13.6.2 Health Services for Children~ ~
784 IV, 13. 6. 2 | 13.6.2.1 Hospitals~ ~Children
785 IV, 13. 6. 2 | 13.6.2.2 Human Resources for
786 IV, 13. 6. 2 | 13.6.2.3 Primary Health Care
787 IV, 13. 6. 2 | 13.6.2.4 School Health and Adolescent
788 IV, 13. 6. 2 | 13.6.2.5 Child Health Service
789 IV, 13. 6. 2 | 13.6.2.6 Pharmaceuticals for
790 IV, 13. 6. 2 | 13.6.2.6 Pharmaceuticals for Children~ ~
791 IV, 13. 6. 3 | 13.6.3 Health Systems and Access
792 IV, 13. 7. 3 | The “Health” theme (EUR 6.0 billion) currently covers
|
|
| |
